Evidence map›Paper›PMID 28155052›Full record

ArticleJournal of materials science. Materials in medicine2017

A nanofibrous electrospun patch to maintain human mesenchymal cell stemness.

L Pandolfi, N Toledano Furman, Xin Wang, C Lupo, J O Martinez, M Mohamed, F Taraballi, E Tasciotti

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

L PandolfiDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.
N Toledano FurmanDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.
Xin WangDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.
C LupoDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.
J O MartinezDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.
M MohamedDepartment of Biomedical Engineering, University of Houston, 4800 Calhoun Rd, Houston, TX, 77004, USA.
F TaraballiDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA. ftaraballi@houstonmethodist.org.ORCID http://orcid.org/0000-0002-4959-1169
E TasciottiDepartment of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.
Houston Methodist · USUniversity of Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have been extensively investigated in regenerative medicine because of their crucial role in tissue healing. For these properties, they are widely tested in clinical trials, usually injected in cell suspension or in combination with tridimensional scaffolds. However, scaffolds can largely affect the fates of MSCs, inducing a progressive loss of functionality overtime. The ideal scaffold must delay MSCs differentiation until paracrine signals from the host induce their change. Herein, we proposed a nanostructured electrospun gelatin patch as an appropriate environment where human MSCs (hMSCs) can adhere, proliferate, and maintain their stemness. This patch exhibited characteristics of a non-linear elastic material and withstood degradation up to 4 weeks. As compared to culture and expansion in 2D, hMSCs on the patch showed a similar degree of proliferation and better maintained their progenitor properties, as assessed by their superior differentiation capacity towards typical mesenchymal lineages (i.e. osteogenic and chondrogenic). Furthermore, immunohistochemical analysis and longitudinal non-invasive imaging of inflammatory response revealed no sign of foreign body reaction for 3 weeks. In summary, our results demonstrated that our biocompatible patch favored the maintenance of undifferentiated hMSCs for up to 21 days and is an ideal candidate for tridimensional delivery of hMSCs. The present work reports a nanostructured patch gelatin-based able to maintain in vitro hMSCs stemness features. Moreover, hMSCs were able to differentiate toward osteo- and chondrogenic lineages once induces by differentiative media, confirming the ability of this patch to support stem cells for a potential in vivo application. These attractive properties together with the low inflammatory response in vivo make this patch a promising platform in regenerative medicine.

Indexed as

AnimalsBiocompatible MaterialsCell AdhesionCell DifferentiationCell ProliferationCell SurvivalChondrocytesChondrogenesisElectrochemistryGene Expression ProfilingHumansImmunosuppressive AgentsInflammationMaterials TestingMesenchymal Stem CellsMiceBiocompatible MaterialsImmunosuppressive Agents

Identifiers

PMID28155052
OpenAlexW2584552584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.